Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Mesenchymal stem cell secretome attenuates disease-associated microglial activation and cognitive decline in TBI-associated neuroinflammation.

Neurochemistry international·2026

Same author

Prominin-1 and Retinal Degenerative Disorders: Expanding the Biology from Photoreceptors to the Retinal Pigment Epithelium.

Biomolecules·2026

Same author

Editorial: Endothelial dysfunction in metabolic disorders: mechanisms, biomarkers, and emerging therapeutics.

Frontiers in pharmacology·2026

Same author

Neurotrauma induced retinal basement membrane COL4A1 defects are restored by adipose tissue derived mesenchymal stem cell concentrated conditioned medium.

Stem cell research & therapy·2025

Same author

Prominin-1 Regulates Retinal Pigment Epithelium Homeostasis: Transcriptomic Insights into Degenerative Mechanisms.

International journal of molecular sciences·2025

Same author

Effects of fasudil against photothrombotic stroke in genetically modified obese (ob/ob) mice.

Metabolic brain disease·2025

Search research articles

Related Experiment Video

Updated: Feb 18, 2026

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Published on: October 6, 2023

Recent Advances in Retinal Stem Cell Therapy.

Sujoy Bhattacharya¹, Rajashekhar Gangaraju¹, Edward Chaum¹

¹Departments of Ophthalmology, and Anatomy and Neurobiology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.

Current Molecular Biology Reports

|November 21, 2017

Summary

This summary is machine-generated.

Stem cell research shows promise for treating blinding eye diseases like retinal degeneration and glaucoma. Further research is needed to optimize cell conversion and delivery for effective clinical application.

Keywords:

Age-related Macular Degeneration (AMD)Induced Pluripotent Stem Cells (iPSCs)Mesenchymal Stem Cells (MSCs)Photoreceptors Retinal ganglion cells (RGCs)Retinal pigment epithelium (RPE)

More Related Videos

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Published on: August 5, 2021

Transpupillary-Guided Trans-Scleral Transplantation of Subretinal Grafts in a Retinal Degeneration Mouse Model

Transpupillary-Guided Trans-Scleral Transplantation of Subretinal Grafts in a Retinal Degeneration Mouse Model

Published on: January 26, 2024

Related Experiment Videos

Last Updated: Feb 18, 2026

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Published on: October 6, 2023

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Published on: August 5, 2021

Transpupillary-Guided Trans-Scleral Transplantation of Subretinal Grafts in a Retinal Degeneration Mouse Model

Transpupillary-Guided Trans-Scleral Transplantation of Subretinal Grafts in a Retinal Degeneration Mouse Model

Published on: January 26, 2024

Area of Science:

Ophthalmology
Regenerative Medicine
Stem Cell Biology

Background:

Stem cell research has advanced significantly over the past decade.
Applications are emerging for retinal degenerative diseases and potentially glaucoma.

Purpose of the Study:

To review the progress and challenges in stem cell therapy for blinding diseases.
To discuss the conversion of stem cells into retinal cell types and delivery methods.

Main Methods:

Review of recent human clinical trials.
Analysis of advancements in in vitro retinal organoid development.
Evaluation of bio-printing and high-resolution imaging technologies.

Main Results:

Human clinical trials highlight both opportunities and limitations of stem cell transplantation.
In vitro retinal organoids, bio-printing, and advanced imaging offer new regenerative possibilities.
These advancements facilitate rigorous in vivo validation of clinical impact.

Conclusions:

Meticulous clinical trials are essential for stem cell transplantation.
Good manufacturing practice, novel surgical techniques, and comprehensive neuronal cell derivation are critical.
Stem cell therapy has the potential to revolutionize the treatment of blinding diseases.